Category: GLP-1 receptor agonist (glucagon-like peptide-1 analogue); antidiabetic and anti-obesity drug

Active substance: semaglutide

Packaging: 1 vials / 5 mg

Half-life: 7 days → administered once weekly (injectable form)

Abused dosage: mainly for weight loss; standard titration from 0.25 mg once weekly up to 2 mg once weekly

Duration of use: long-term treatment